Key result
South Asian ethnicity linked to ~2.6-fold higher 1-year major cardiovascular events in diabetic STEMI patients.
Why the study?
The frequency and impact of diabetes on cardiovascular outcomes in South Asian compared with white North American patients with STEMI undergoing PPCI were not well characterized.
Does South Asian ethnicity worsen 1-year cardiovascular outcomes compared to white North American ethnicity in patients with and without diabetes undergoing primary PCI for STEMI?
Cohort (n=1,303)
Does South Asian ethnicity worsen 1-year cardiovascular outcomes compared to white North American ethnicity in patients with and without diabetes undergoing primary PCI for STEMI?
Answers are grounded in this paper and cite their sources.
Among patients undergoing primary PCI for STEMI, South Asian patients have a higher prevalence of diabetes and, if diabetic, face significantly worse 1-year mortality and cardiovascular outcomes compared to white North American patients.
The aim of this study was to examine the frequency and impact of diabetes (DM) in South Asian (SA) compared with white North American (WNA) patients with ST-elevation myocardial infarction (STEMI). Consecutive patients undergoing primary percutaneous coronary intervention (PPCI) for STEMI between 2016 and 2018 were included for analysis. Patients with and without DM were divided into distinct cohorts. Cardiovascular outcomes at 1-year, including mortality and composite major adverse cardiovascular events (MACE), were compared between SA and WNA in each cohort. Overall, 1,303 patients underwent PPCI for STEMI. Average age for patients was 63.81 ± 12.48 years, 73.4% were male and 27% had DM at the time of presentation. Patient ethnicity was distributed as 407 (31%) SA and 896 (69%) WNA. DM was significantly more frequent in SA compared with WNA (34% vs 24%, p <0.01). In the DM cohort, SA were more likely to have multivessel disease on coronary angiography (SA 55% vs WNA 44%, p = 0.04) and had significantly increased mortality (SA 14% vs WNA 7%, p = 0.04) and mortality/MACE (SA 22% vs WNA 12%, p <0.01) 1-year after PPCI. In multivariate analysis of 1-year outcomes amongst DM, SA ethnicity was an independent predictor of both mortality (odds ratio [OR] 2.82, 95% confidence interval [CI] 1.15, 6.89) and mortality/MACE (OR 2.62, 95% CI 1.33, 5.16). In the non-DM cohort, SA ethnicity was not associated with outcomes or presence of multivessel disease. In conclusion, SA compared to WNA with STEMI were more likely to have DM, while SA ethnicity amongst DM patients conferred worsened 1-year prognosis for cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) conducted a cohort in ST-elevation myocardial infarction (n=1,303). South Asian ethnicity vs. White North American ethnicity was evaluated on 1-year mortality/MACE in patients with diabetes (OR 2.62, 95% CI 1.33-5.16, p=<0.01). Among diabetic patients with STEMI, South Asian ethnicity was independently associated with increased 1-year mortality/major cardiovascular events compared to White North Americans.
Synapse has enriched 10 related papers. Consider them for comparative context: